A nationally recognized leader in healthcare fraud and abuse, Howard Young has advised healthcare organizations and life science companies for almost 30 years and brings a solutions-oriented approach to address their complex legal and regulatory needs. Howard has held senior leadership positions in the federal government and in private practice, and currently co-leads the firm’s global healthcare industry team and sits on the Chair’s Advisory Board. Howard counsels on government investigations and audits, litigation, regulatory, and transactional matters.
Healthcare organizations turn to him for compliance and strategic business issues, to handle internal and government investigations, False Claims Act (FCA) qui tam litigation, Department of Health and Human Services (HHS) Office of Inspector General (OIG) inquiries, and government self-disclosures. Howard regularly advises investors, including private equity firms, and providers on transactions, affiliations, and joint ventures.
Howard’s clients include a wide range of providers and suppliers, including hospice and palliative care, home health, long term care, specialty and retail pharmacies, hospitals and academic medical centers, behavioral health providers, physician practices, vision care providers, medical device manufacturers and suppliers, telehealth providers, healthcare vendors, pharmacy benefit managers (PBMs), health plans, and distributors.
As a former senior managing lawyer with the HHS OIG, Howard has experience advising and litigating on OIG and state exclusion matters, and successfully litigated a mandatory exclusion matter in federal court (the only instance when a federal court has reversed an OIG exclusion action). He also assists clients responding to program integrity actions of the Centers of Medicare & Medicaid Services (CMS) contractors, such as the unified program integrity contractors (UPICs) and Supplemental Medical Review Contractor, regarding audits and billing revocation and payment suspensions, as well as OIG audits and investigations. During the COVID-19 public health emergency, Howard advised a wide array of healthcare organizations on federal and state waivers, CARES Act grant issues, OIG audit readiness, and OIG response issues.
Howard frequently writes and presents on fraud and abuse and healthcare regulatory issues to major healthcare trade and professional associations as well as to clients’ executive teams, boards of directors, and sales and marketing personnel.
Named, Modern Healthcare’s “Largest Healthcare Firm” (2016–2021)
Recommended, Industry Focus - Healthcare - Health Insurers, Service Providers, The Legal 500 US (2016-2021)
Ranked, Healthcare: Regulatory & Litigation, Nationwide, Chambers USA (2018, 2019)
Band 1, Healthcare, District of Columbia, Chambers USA (2020, 2021)
Ranked, Healthcare, District of Columbia, Chambers USA (2018, 2019)
Ranked, Chambers USA: America's Leading Lawyers for Business (2006–2017)
Recognized, Washington DC Super Lawyers (2012–2018)
Recognized, Washingtonian magazine "Best Lawyers" (2013, 2014)
Life Sciences Star, Fraud and Abuse (2012–2016); Non-IP Litigation and Enforcement (2016–2021), LMG Life Sciences
Litigation Star and Local Litigation Star in White Collar Crime, Benchmark Litigation (2015–2018)
Outstanding Healthcare Fraud and Compliance Lawyer, Nightingale's (2010)
Recipient, 1998 and 2002 OIG Exceptional Achievement Awards; 2000 President's Council on Integrity and Efficiency Award; 2001 OIG Cooperative Achievement Award for Multi-Agency Enforcement Efforts
Member, American Health Lawyers Association
Member, American Society of Pharmacy Law
Member, Health Law Section, American Bar Association
Member, Health Care Compliance Association
Member, Healthcare Editorial Advisory Board, Law360 (2017)